Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$30.12+1.82 (+6.43%)
Close on Nov 13, 2026Market cap $1.13BP/E –Yield –
Harrow cash
Cash and short-term investments held at the end of each period.
Harrow's cash was $75.34M at Sep 30, 2026. For fiscal 2025 it was $72.93M, up 54.4% from the year before. Over ten years it grew 39.1% a year on average. The highest annual figure on record is $101.86M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $72.93M | +54.4% |
| FY2024 | Dec 31, 2024 | $47.25M | -42.9% |
| FY2023 | Dec 31, 2023 | $82.77M | -18.7% |
| FY2022 | Dec 31, 2022 | $101.86M | +101.0% |
| FY2021 | Dec 31, 2021 | $50.67M | +55.6% |
| FY2020 | Dec 31, 2020 | $32.56M | +585.5% |
| FY2019 | Dec 31, 2019 | $4.75M | -30.5% |
| FY2018 | Dec 31, 2018 | $6.84M | +62.1% |
| FY2017 | Dec 31, 2017 | $4.22M | -53.4% |
| FY2016 | Dec 31, 2016 | $9.05M | +237.2% |
| FY2015 | Dec 31, 2015 | $2.69M | -67.3% |
| FY2014 | Dec 31, 2014 | $8.21M | -47.3% |
| FY2013 | Dec 31, 2013 | $15.58M | +55.2% |
| FY2012 | Dec 31, 2012 | $10.04M | +6766.2% |
| FY2011 | Dec 31, 2011 | $146.16K | -49.9% |
| FY2010 | Dec 31, 2010 | $291.46K | -81.7% |
| FY2009 | Dec 31, 2009 | $1.59M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $75.34M | +1.4% |
| Q2 FY2026 | Jun 30, 2026 | $83.89M | +58.4% |
| Q1 FY2026 | Mar 31, 2026 | $94.64M | +41.8% |
| Q4 FY2025 | Dec 31, 2025 | $72.93M | +54.4% |
| Q3 FY2025 | Sep 30, 2025 | $74.29M | +2.3% |
| Q2 FY2025 | Jun 30, 2025 | $52.96M | -25.4% |
| Q1 FY2025 | Mar 31, 2025 | $66.73M | -12.2% |
| Q4 FY2024 | Dec 31, 2024 | $47.25M | -42.9% |
| Q3 FY2024 | Sep 30, 2024 | $72.60M | -1.7% |
| Q2 FY2024 | Jun 30, 2024 | $70.97M | +139.2% |
| Q1 FY2024 | Mar 31, 2024 | $75.97M | +182.6% |
| Q4 FY2023 | Dec 31, 2023 | $82.77M | -18.7% |
| Q3 FY2023 | Sep 30, 2023 | $73.88M | +50.4% |
| Q2 FY2023 | Jun 30, 2023 | $29.67M | -42.5% |
| Q1 FY2023 | Mar 31, 2023 | $26.88M | -46.9% |
| Q4 FY2022 | Dec 31, 2022 | $101.86M | +101.0% |
| Q3 FY2022 | Sep 30, 2022 | $49.12M | -27.4% |
| Q2 FY2022 | Jun 30, 2022 | $51.63M | -39.2% |
| Q1 FY2022 | Mar 31, 2022 | $50.59M | +702.5% |
| Q4 FY2021 | Dec 31, 2021 | $50.67M | +55.6% |
| Q3 FY2021 | Sep 30, 2021 | $67.65M | +1081.2% |
| Q2 FY2021 | Jun 30, 2021 | $84.86M | +1968.7% |
| Q1 FY2021 | Mar 31, 2021 | $6.30M | +52.9% |
| Q4 FY2020 | Dec 31, 2020 | $32.56M | +585.5% |
| Q3 FY2020 | Sep 30, 2020 | $5.73M | +57.7% |
| Q2 FY2020 | Jun 30, 2020 | $4.10M | -2.2% |
| Q1 FY2020 | Mar 31, 2020 | $4.12M | -3.3% |
| Q4 FY2019 | Dec 31, 2019 | $4.75M | -30.5% |
| Q3 FY2019 | Sep 30, 2019 | $3.63M | -42.5% |
| Q2 FY2019 | Jun 30, 2019 | $4.19M | +0.6% |
| Q1 FY2019 | Mar 31, 2019 | $4.27M | +47.5% |
| Q4 FY2018 | Dec 31, 2018 | $6.84M | +62.1% |
| Q3 FY2018 | Sep 30, 2018 | $6.32M | +55.3% |
| Q2 FY2018 | Jun 30, 2018 | $4.17M | -4.5% |
| Q1 FY2018 | Mar 31, 2018 | $2.89M | -60.9% |
| Q4 FY2017 | Dec 31, 2017 | $4.22M | -53.4% |
| Q3 FY2017 | Sep 30, 2017 | $4.07M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.37M | – |
| Q1 FY2017 | Mar 31, 2017 | $7.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.05M | – |
See a number that looks wrong?